China Approves the First Brain Computer Chip

There’s a buzz in the tech world. Hackers are intrigued, surveillance advertisers are thrilled, and the political guardians of ideology are fixated.

China has taken a significant step by approving the world’s first brain computer chip.

Interestingly, they beat out notable figures like Elon Musk in this competitive field.

The tiny device, named NEO, represents the first surgical implant to successfully complete clinical trials and enter the commercial market.

This initial version aims to aid patients recovering from spinal cord injuries and paralysis. Production is set to kick off for China’s government-operated medical system.

Both the Chinese Communist Party and Musk view this as merely the starting point toward developing highly efficient and compliant human cyborgs.

Musk, who’s recently been promoting the advantages of such technology, remarked, “Restoring control and vision for quadriplegics is quite significant.”

His venture, Neuralink, promises to enable users to carry out tasks solely by thinking, such as typing or maneuvering a computer mouse.

While concepts of curing paralysis, restoring sight, or even raising the dead feel distant, the advancements in brain technology seem far less abstract now.

Proponents of BrainChip envision a future filled with extraordinary abilities like digital telepathy.

Musk, a known supporter of Trump and a prominent MAGA advocate, even suggested that brain chips could help combat what he calls a “walking mind virus,” hinting at the capability to record memories and address psychological issues.

Dr. David Tuffley, a cybersecurity expert, expressed a cautiously optimistic view, saying, “While brain implants may seem unsettling, they hold promise in neuroscience research.”

However, he noted that such technology could give hackers access to deeply personal neurological information.

Emerging Cyborg Era

“We’re on the verge of a major evolution, merging humans with AI,” said venture capitalist Scott Phoenix at a recent TED Talk.

He added, “Those close to you might adopt this first. Just like smartphones, there may be some hesitation, but ultimately, integration will prove hard to resist.”

This outlook aligns with thoughts from OpenAI’s Sam Altman and Peter Thiel.

A recent analysis from Future Market Insights predicted the brain-computer interface market, currently valued at around $490 million, could surge to about $1.7 billion by 2035.

There’s a lot at stake, both financially and for the future of humanity.

A pressing issue remains: who owns the data harvested from our brains?

This could be a significant trade-off for customers who rely on these advancements.

These brain chips could potentially enhance life for over 3 billion individuals battling neurological disorders related to movement and language, alongside conditions like depression and Parkinson’s disease.

Yet, they raise privacy concerns that surpass the risks associated with standard technologies.

The data gathered is already invaluable to large marketing firms and cybercriminals alike.

“Hacking could not only alter cognitive functions but also manipulate motor signals, affecting a patient’s movement,” Dr. Tuffley elaborated, highlighting the risk as these devices gain popularity.

Ongoing Challenges

Brain-computer technology is still far from perfect.

The complexities of inserting a foreign device into the body are daunting.

The human body often reacts defensively, creating barriers around such objects.

There’s also a threat of damage to tissues the device interacts with.

Researchers at Tsinghua University and Neuracle Technology in Shanghai are focused on mitigating these dangers.

The NEO sits between the skull and brain, with sensors that connect to a computer, translating brain waves into digital commands.

Currently, 36 patients are testing the implant, showing promising results.

This poses challenges for Musk’s Neuralink, which hasn’t yet received FDA approval, despite entering clinical trials in 2024.

Some experts suggest the non-invasive design of the Chinese implant contributes to its head start.

Neuralink’s device, in contrast, requires insertion into the cerebral cortex.

“The risks of physical damage are real and can impair surrounding brain functionality,” Dr. Tuffley pointed out.

For instance, even minor complications like a small blood clot can affect speech or motor skills.

As it stands, Neuralink is still trialing its device on a handful of patients.

One participant, Audrey Crews, shared her journey on social media, expressing hope that her experience will help improve technology that could someday allow extensive mind control over devices.